The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy

Statins and/or PCSK9 inhibitors cause the regression of coronary atheroma and reduce clinical events. However, it currently remains unclear whether these drugs modulate coronary atheroma calcification in vivo. Coronary artery calcium (CAC) scores (Agatston Units, AUs) were estimated in 120 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikegami, Yuichi, Inoue, Ikuo, Inoue, Kaiji, Shinoda, Yuichi, Iida, Shinichiro, Goto, Seiichi, Nakano, Takanari, Shimada, Akira, Noda, Mistuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015059/
https://www.ncbi.nlm.nih.gov/pubmed/29951223
http://dx.doi.org/10.1038/s41514-018-0026-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015059/
https://www.ncbi.nlm.nih.gov/pubmed/29951223
http://dx.doi.org/10.1038/s41514-018-0026-2

Ejemplares similares